Following 30 years of research and development, the first malaria vaccine…								
				Category: Clinical Trials
					Home / Clinical Trials / Page 3				
				
									Recent advancements have led to the development of new cancer therapies…								
				
									A recent Phase III clinical trial found that lecanemab reduces cognitive…								
				
									In August 2022, the Food and Drug Administration (FDA) approved Cimerli™…								
				
									In 2018 the word “hangry,” the portmanteau of hungry and angry,…								
				
									Russia’s invasion of Ukraine is causing what the Financial Times called…								
				
									Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including…								
				
									When designing pediatric clinical drug trials, it’s important to work with…								
				
									Children are not little adults, but due to a lack of…								
				
									In the pharmaceutical and biotechnology industry more small and even virtual…								
				
									Did you know that only about 20 percent of drugs used…								
				
									Shoulder to shoulder with our clients, we at QPS like to…								
				
									Two companies have just selected QPS Netherlands to conduct their First-in-Human…								
				
									An investigation into the efficacy and safety of Estetrol (E4) for…								
				
									Patient recruitment is one of the most critical foundations of any…								
				
									QPS has been assisting an international Sponsor to perform a global,…								
				
									QPS has been assisting an international Sponsor to perform a global,…								
				
									The European Medicines Agency (EMA) has released a draft guideline revision…								
				
									Making the right decision about where to conduct Phase I of…								
				
									Okay, we’ll admit it: a company telling you about their new…								
				
									Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…								
				
									Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…								
				
									Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…								
				
									NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…								
				
									NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…								
				
									TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…								
				Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
				QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
				
First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
					
			March 6, 2023		
				
				Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children living

Attacking KRAS Proteins to Kill Cancer
					
			December 14, 2022		
				
				Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021, the

New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
					
			November 16, 2022		
				
				A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants who

FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
					
			October 17, 2022		
				
				In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription costs

Hangry Is Officially a Thing. So, What Should We Do About It?
					
			August 8, 2022		
				
				In 2018 the word “hangry,” the portmanteau of hungry and angry, was finally added to the Oxford English Dictionary. We say finally because the concept

War in Ukraine Impacts Clinical Research Industry
					
			May 18, 2022		
				
				Russia’s invasion of Ukraine is causing what the Financial Times called a “many-sided economic shock,” sending global prices sky-high for goods ranging from fuel to

Using Video Games for Early Detection of Parkinson’s Disease
					
			August 3, 2020		
				
				Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including bradykinesia (slowed movement and loss of spontaneous movement), muscular rigidity, resting tremors and postural

Working with Families in Pediatric Clinical Drug Trials
					
			October 1, 2019		
				
				When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If certain

Guidance for Scheduling Clinical Trials in Children
					
			September 24, 2019		
				
				Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved for

New Horizons for Patient Studies at QPS-NL
					
			September 13, 2019		
				
				In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug development.
Solutions for Recruitment for Pediatric Clinical Trials
					
			September 3, 2019		
				
				Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are often

Spreading Early Clinical Knowledge
					
			October 20, 2017		
				
				Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature.
QPS Tapped for Two New FIH Studies
					
			May 5, 2017		
				
				Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute ischemic
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
					
			May 2, 2017		
				
				An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
					
			May 4, 2016		
				
				Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
					
			April 19, 2016		
				
				QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
					
			March 2, 2016		
				
				QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
					
			February 15, 2016		
				
				The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
					
			January 6, 2016		
				
				Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled,
Specialized, Collaborative Clinical Development Services Provide Peace of Mind for Clients
					
			August 18, 2015		
				
				Okay, we’ll admit it: a company telling you about their new brochure seems about as interesting as looking through your Great Uncle’s vacation pictures –
									Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…								
				
									Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…								
				
									Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…								
				
									NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…								
				
									NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…								
				
									TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…